And a new poll: when will CMS announce the next 15 meds up for price controls?
And four reasons why I'm happy to be skipping JPM this year (tomorrow, I'll give four reasons why skipping might be a mistake)
Plus my contribution to the "2025 Advice" series: Ditch the press release and file a lawsuit instead.
Plus data and insights on "Jan. 1" price changes, thinking on "smoothing", small PBMs in 2025, and more
Plus some of the 2025 advice you all have sent along (the survey is still live, too!)
It's a slow day, but I still managed to find at least one 340B link, because I want to stay on-brand
But I have some suggestions for reporters looking for a way to stay busy this week without chasing the same, tired price-increase story
And thank you, President Carter, for teaching us all how much global public health matters
Have a great holiday, everyone!
And thanks to everyone who weighed in on the future of Cost Curve. With that feedback, I'm committed to making 2025 a banner year
And PBM reform seems to be dead. For now. Maybe. (I'm choosing to think that reform is merely pining for the fjords)